{{Rsnum
|rsid = 10897346
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Chromosome=11
|position=55863349
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}Carriers of [[rs10897346]](C) alleles showed a 2.6-fold increased risk (CI: 1.4-4.8) for nonresponse to all major types of anti-depressant drugs (such as the [[SSRI]] drug [[citalopram]]) in a study of 182 German patients.{{PMID|18496129}}

{{PharmGKB
|RSID=rs10897346
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18496129
|Annotation=This SNP was significantly associated with response to therapy in 182 patient who received treatment for major depression.
|Drugs=mirtazapine; venlafaxine
|Drug Classes=
|Diseases=Depression
|Curation Level=Curated
|PharmGKB Accession ID=PA162190496
}}

{{PMID|21172166|OA=1
}} Pharmacogenetics of antidepressant response.

{{on chip | 23andMe v3}}
{{on chip | HumanOmni1Quad}}